Abstract
Hyoscine N-Butyl Bromide (HBB) was subjected to different ICH prescribed stress conditions. It showed extensive decomposition under base hydrolytic conditions, while it was less liable to stress acid hydrolytic conditions. It showed also moderate degradation in response to oxidation stress of hydrogen peroxide. The drug showed no changes under photolysis conditions. In total, a number of major degradation products were detected by HPLC and identified by LC-MS. For establishment of stability-indicating assay, the reaction solutions in which different degradation products were formed were prepared, and the separation was optimized by varying the HPLC conditions. An acceptable chromatograms was achieved using a C18 column using (water: methanol 50: 50 v/v, pH adjusted to 3.9 with triflouroacetic acid) as a mobile phase with flow rate of 1.0 ml min−1 and UV detection wavelength at 210 nm. The percent of degradation was calculated in each run by measuring the intensity of the peak area of the intact drug at 6.2 min. Complete degradation only occur in case of 5 N NaOH indicates that the drug is very sensitive to alkaline hydrolysis. The LC-MS study was carried out to identify the major degradation products using a sunfire (waters) C-18 column and a mobile phase comprising of acetonitrile: 0.1M ammonium acetate (80:20, v/v) with flow rate of 1.0 ml min−1. MS measurements were acquired in positive ion full scan modes from 50 to 400 amu. The m/z values of the main peaks were investigated with the expected chemical structure of degradates.
Highlights
Hyoscine N-Butyl Bromide is a quaternary ammonium anticholinergic agent
Selective, sensitive and accurate isocratic HPLC method was adopted for the determination of Hyoscine N-Butyl Bromide (HBB) in presence of degradation products without prior separation
Mass spectrum scanning by LC-MS was developed for determination of degradation behavior of HBB and Characterization of degradation product(s)
Summary
Hyoscine N-Butyl Bromide is a quaternary ammonium anticholinergic agent. Doi:10.4172/2153-2435.S7-006 stability-indicating analytical method for HBB has been published in the literature, a UPLC/MS-MS method for determination of the drug in plasma has been published [8]. This method does not discuss the identity of the degradation products and does not offer a stability study. Hyoscine N-Butyl Bromide (HBB) was kindly supplied by CID Co. Chemical Industries Development, Giza, Egypt. The system consist of pump (Shimadzu LC20AD), auto injector (Shimadzu SIL20A), the device is
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.